1[1]Ferenci P,Lockwood A,Mullen K,et al.Hepatic encephalopathy-definition,nomenclature,diagnonsis and quantification:final report of the working party at the 11th world congresses of gastroenterology.Vienna,1998.Hepatology,2002,35:716～721
2[2]Weissenborn K,Ennen JC,Schomerus H,et al.Neuropsychological characterization of hepatic encephalopathy.J Hepatol,2001,34:768～773
3[3]Kircheis G,Wettstein M,Timmermann L,et al.Critical flicker frequency for quantification of low grade hepatic encephalopathy.Hepatology,2002,35:357～366
4[4]Hindmarch I,Shamsi Z,Stanley N,et al.A double-blind,placebo-controlled investigation of the effects of fexofenadine,loratadine and promethazine on cognitive and psychomotor function.Br J Clin Pharmacol,1999,48:200～206
5[5]Laubenberger J,Haussinger D,Bayer S,et al.Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis.Gastroenterology,1997,112:1610～1616
6[6]Lee SS,Mathiasen RA,Lipkin CA,et al.Endoscopically placed nasogastrojejunal feeding tubes:a safe route for enteral nutrition in patients with hepatic encephalopathy.Am Surg,2002,68:196～200
7[7]Blei AT,Cordobe J.The practice parameters committee of the American college of gastroenterology:hepatic encephalopathy.Am J Gastroenterol,2001,96:1996～1975
8[8]Marchesini G,Fabbri A,Biaachi G,et al.Zinc supplementation and aminoacid-nitrogen metabolism in patients with advanced cirrhosis.Hepatology,1996,23:1082～1092
9[9]Curioso WH,Monkemuller KE.Neomycin should not be used to treat hepatic encephalopathy.BMJ,2001,322:416～418
10[10]Vasconez C,Elizalde JI,Liach J,et al.Helicobacter pylori,hyperammonemia and subclinical portosystemic encephalopathy:effect of eradication.J Hepatol,1999,30:260～264
